TrialAntiviral therapy2017

Treatment of HIV infection with a raltegravir-based regimen increases LDL levels, but improves HDL cholesterol efflux capacity.

Nicholas T Funderburg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.